Drug Regulator Directs J&J To Pay Rs 74.5 Lakh To First Patient With Faulty Hip Implant
A logo sits on a wall inside Johnson & Johnson’s innovation centre in London, U.K. (Photographer: Simon Dawson/Bloomberg)

Drug Regulator Directs J&J To Pay Rs 74.5 Lakh To First Patient With Faulty Hip Implant

Bookmark
The Central Drugs Standard Control Organisation has directed Johnson and Johnson to pay Rs 74,57,180 to the first patient from Mumbai who received faulty hip implants made by the company based on t...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.